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This review addresses current advances in gastroesophageal reﬂux disease (GERD) and its inﬂuence on
sleep and health-related quality of life (QOL). Sleep difﬁculties are highly prevalent among adults with
GERD, especially those who experience nighttime symptoms. These sleep difﬁculties result in substantial
costs to the health care system by increasing provider visits. Because continued sleep disruption leads to
increased daytime sleepiness and fatigue, nocturnal heartburn can reduce work productivity, as well as
reduce function when performing normal daily activities. The continued presence of nocturnal symp-
toms in routine medical treatment is strongly associated with decreases in health-related quality of life.
There is a greater loss of productivity to the employer and poorer health-related QOL (HRQOL) for the
patient. Obstructive sleep apnea syndrome and obesity seem to predispose some patients to nocturnal
GERD, and the presence of either of these conditions may help to identify patients with symptoms
consistent with GERD. Appropriate management of GERD must include treatment of nighttime reﬂux
symptoms that affect difﬁculty in both initiating and maintaining sleep.
Copyright  2012, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Not uncommonly, clinicians observe that patients who are
effectively treated for severe heartburn spontaneously, report that
they are sleeping better in addition to achieving a resolution of
their reﬂux symptoms. These reports from patients have focused
attention on the relationship between gastroesophageal reﬂux
(GER) during sleep and the extent to which this phenomenon
results in disturbances of sleep and its associated complications.
With the evolution of current knowledge documenting physiologic
and psychological changes associated with sleep, as well as
a variety of sleep-related problems associated with GER, an
awareness of the relationship between sleep and GER disease
(GERD) has rapidly emerged. Perhaps the most notable of the more
recent focus on gastrointestinal complaints, is the relationship
between sleep-related GER and the development of esophageal and
extraesophageal complications. In some recent epidemiological
studies, which have focused on nighttime heartburn, there has
been a particular focus on the issue of nighttime heartburn related, Buddhist Tzu Chi General
aiwan. Tel.: þ886 3 8561825;
Chen).
ddhist Compassion Relief Tzu Chito the consequences of sleep disturbance and reduction in quality
of life (QOL).
GERD is a highly prevalent disorder that affects a substantial
proportion of the population globally. Fifteen percent of US adults
experience symptoms of GERD (heartburn and regurgitation) at
least once a week [1]. The fact that symptoms of heartburn are
readily treated with antacids, histamine-2 receptor antagonists,
and more recently, proton-pump inhibitors, has obscured the
frequency and importance of the symptoms of nighttime heart-
burn. Thus, until recently, clinicians would rarely, if ever, inquire
about the frequency, characteristics, and consequences of night-
time heartburn.2. Nighttime symptoms and sleep disturbances
We have previously attempted to determine whether patients
with signiﬁcant nighttime heartburn had more disturbed sleep and
more GER than those without signiﬁcant nighttime heartburn [2].
Thirty-three reﬂux patients were stratiﬁed into two groups
(nighttime heartburn, without nighttime heartburn). After
completing questionnaires assessing daytime and nighttime
heartburn and subjective sleep with the Pittsburgh Sleep Quality
Index (PSQI), all participants underwent 24-hour esophageal pH
monitoring and an overnight polysomnographic study. We foundFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
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signiﬁcantly greater in patients with nighttime heartburn than in
those without nighttime heartburn for the total and upright posi-
tion periods. Acid contact time was signiﬁcantly greater in patients
with nighttime heartburn during the upright period and during the
total period. Patients with nighttime heartburn reported signiﬁ-
cantly greater subjective sleep impairment (8.1  0.7) than those
without nighttime heartburn (6.10.4; p¼ 0.02). It was concluded
that patients with signiﬁcant nighttime heartburn seem to have
more acid reﬂux than those without nighttime heartburn. Night-
time heartburn together with sleep complaints is associated with
excessive GER.
Several studies have recently focused attention on both QOL and
the sleep disturbance consequences of nighttime heartburn. In
understanding how to interpret these data, it is important to
understand how “nighttime heartburn” is deﬁned. In general, these
studies deﬁne nighttime as the time when the patient lies down to
attempt to go to sleep until waking in the morning occurs. Among
the ﬁrst of these observations was a survey by Janson and
colleagues [3] of the general population in several Scandinavian
countries. The authors found a signiﬁcant relationship between
nighttime heartburn at least once a week and daytime sleepiness,
daytime tiredness, and snoring. Symptoms of GER were associated
with daytime sleepiness [odds ratio (OR) ¼ 2.6], daytime tiredness
(OR ¼ 4.5), and disrupted breathing (OR ¼ 3.8). The relationship
between snoring and GER at least one night per week showed an
OR ¼ 2.75. Another epidemiologic study conducted by Farup and
colleagues [1] described the impact of nighttime heartburn on
health-related QOL (HRQOL). In this study, nighttime heartburn
was reported to be a common symptom in patients with frequent
daytime heartburn. The authors reported that 74% of those indi-
viduals with frequent heartburn had symptoms of nighttime
heartburn. It was also noted that individuals who reported night-
time heartburn were signiﬁcantly more impaired with regard to
QOL than subjects who reported daytime symptoms only. Individ-
uals with nighttime heartburn reported signiﬁcantly more pain
than patients with diabetes and similar pain compared to thoseTable 1




2007 GERD (n ¼ 64) Observational study Polysomn
pH monit
2007 GERD (n ¼ 48) Observational study Endoscop
2008 GERD (n ¼ 33) Observational study Polysomn
pH monit
2008 GERD ((n ¼ 81) Observational study Polysomn
pH monitControls ((n ¼ 39)
2008 RE (n ¼ 10) Cross-over case-control
study
Actigraph
Controls (n ¼ 10)
2009 GERD ((n ¼ 39) Observational study Actigraph
pH monit
GERD ¼ gastroesophageal reﬂux disease; RE ¼ reﬂux esophagitis.with angina and congestive heart failure. Recently, a strong asso-
ciation between GERD and sleep disturbances as a cause of altered
daytime performance has been extensively investigated (Table 1)
[2,4e9].
This surprising prevalence of nighttime heartburn has been
described in a more recent study by Shaker and colleagues [10]. In
this study, a nationwide telephone survey of 1000 adults experi-
encing heartburn at least once a week was conducted on behalf of
the American Gastroenterological Association. The results revealed
that 79% of respondents reported experiencing nighttime heart-
burn. Among these individuals, 75% reported that symptoms
altered their sleep, and 63% believed that nighttime heartburn
negatively affected their ability to sleep well. Forty percent of
patients with nighttime heartburn believed that these nocturnal
symptoms impaired their ability to function the following day. Of
particular interest was the fact that the prevalence of sleep
disturbances among the respondents increased with increasing
frequency of nighttime heartburn episodes over the course of
a week. That is, individuals who had nighttime heartburn three
times a week had complaints of being kept awake (67%) and of
waking up during the night (70%). A surprising percentage (16%) of
these individuals reported trying sleep medications to treat their
presumed GER-related sleep disturbance. Patients with nighttime
heartburn had tried a variety of treatment mechanisms in addition
to sleeping pills, but with surprisingly poor success. For example,
41% of this patient population indicated that they used prescription
medications, but less than half reported that they were satisﬁed
with this treatment approach. A similar percentage of individuals
had also tried elevation of the head of the bed, but only 23% re-
ported satisfaction with this treatment approach.
3. Effects of GERD on sleep and HRQOL
Sleep-related GER can result in more than disturbed sleep.
Recently, Mody et al examined the relationship between reﬂux
symptoms during sleep, sleep onset, and sleep maintenance
insomnia and assessed the effects of reﬂux-related sleep difﬁcultiesion Main ﬁndings
ography with esophageal
oring
The total reﬂux time, frequency
of acid reﬂux event and number
of sensed reﬂux events was signiﬁcantly
higher in both the upright and
supine-awake period than supine
asleep [5]
y, esophageal pH monitoring Reciprocal relationship between
GERD symptoms/acid exposure
and sleep quality [6]
ography with esophageal
oring
Prolonged acid contact time in
patients with nighttime heartburn
compared to controls. Nighttime
heartburn related with subjective,
but not objective sleep impairment [2]
ography with esophageal
oring
No difference in reﬂux event (27%
vs. 33%); prolonged acid exposure
time in sleep disturbance compared
to controls (9.5% vs. 1.6%; p < 0.05) [7]
y with acid perfusion test Sleep deprivation provoked acid
hypersensitivity in patients with RE
and increased GERD symptom severity [8]
y with esophageal
oring
Comparison of reﬂux characteristics
during the upright, recumbent-awake,
and recumbent-asleep periods. Short
acid reﬂux events during sleep related
with conscious awakenings [9]
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According to their survey of 11,685 respondents with reﬂux symp-
toms, 68% experienced sleep difﬁculties, with 49% reporting sleep
onset insomnia and 58% reporting sleep maintenance insomnia.
Respondents with reﬂux symptoms during sleep time were also
more likely to have sleep onset insomnia (OR ¼ 1.43) and sleep
maintenance insomnia (OR ¼ 1.56) compared to respondents with
reﬂux symptoms only during wakefulness. Furthermore, respon-
dentswith reﬂuxwith sleep difﬁculty hadmorehealth careprovider
visits, a loss of 5.5% in their work productivity, and reductions in
their HRQOL. Thus, reﬂux during the sleeping interval affects the
ability to sleep, as well as wake-time functioning and QOL.
Among adults with GERD, nighttime symptoms signiﬁcantly
affected sleep difﬁculties, and sleep difﬁculties were negatively
correlatedwith HRQOL. The evidence is supported by a studywhich
found that patients with nighttime GERD symptoms reported lower
HRQOL than those without nighttime symptoms [1]. Among
respondents with GERDwho had sleep difﬁculties, the mean Short-
Form (SF)-8 physical and mental summary scores were substan-
tially poorer than those in the general population [1]. After
adjusting for differences in personal and clinical characteristics, the
differences in SF-8 physical and mental summary scores between
those with and without sleep difﬁculties were >3 points each. A
recent study has shown that a 3-point change in the SF-36, and by
extension the SF-8, is a clinically meaningful difference [12].
Therefore, the negative effects of sleep difﬁculties on HRQOL were
not only statistically signiﬁcant, but had meaningful clinical
implications. These data are also supported by other epidemio-
logical studies, which indicate that nighttime reﬂux symptoms are
more problematic and may predict GERD with more severe
presentations [13,14]. These studies applying an internet survey
suggest that individuals with nighttime reﬂux symptoms have
a greater frequency and severity of GERD symptoms, as well as
atypical symptoms such as chronic cough, hoarseness, and chest
pain. Thus, awareness of signiﬁcant nighttime symptoms in clinical
practice might help identify those individuals at greater risk of
developing esophagitis and other complications of GERD, and who
thus require more aggressive treatment.
4. Consequences of resolving nighttime symptoms
An epidemiologic study of general symptomatic GERD patients
(n¼ 6215) revealed similar results in terms of diminished QOL [15].
Kulig and colleagues found that the generic QOL of these patients
was diminished, and that QOL was signiﬁcantly improved in
patients with erosive GERD, non-erosive GERD, as well as Barrett’s
esophagus, after 2 weeks of treatment with esomeprazole. Baseline
QOL in this cohort of GERD patients was comparable to that of
patients with coronary artery disease. Treatment resulted in
a similar improvement in QOL in all three subpopulations of GERD
patients, indicating that endoscopic results and severity appeared
to be unrelated to QOL measures. This study indicates that QOL
measures can be substantially and signiﬁcantly improved quickly,
with appropriate resolution of symptoms. This study did not
address the issue of nighttime GERD.
Other studies have more formally documented the presence of
sleep disturbances in patients with nighttime GERD, as well as
response to treatment. Chand and colleagues [16] studied 18
patients with erosive esophagitis using subjective GERD rating
scales, the PSQI, and ambulatory wrist actigraphy (a deviceworn on
the wrist that monitors motion and provides information on the
sleep state). Patients were assessed at 4 and 8 weeks subsequent to
treatment with esomeprazole 40 mg/day. In this cohort of patients,
the baseline sleep efﬁciency, determined via wrist actigraphy, was
87%, which is indicative of a signiﬁcant sleep disturbance. The PSQIand GERD symptom questionnaire scores were signiﬁcantly
improved after both 4 and 8 weeks of treatment.
Results from a randomized clinical trial involving patients with
both nighttime heartburn and sleep disturbance were recently
published by Johnson and colleagues [17]. This multicenter,
randomized, double-blind, placebo-controlled trial included adults
with GERD-associated sleep disturbances and moderate to severe
nighttime heartburn, as noted by a subjective patient diary. Patients
received either 20 mg or 40 mg of esomeprazole or placebo once
daily for 4 weeks. Outcome variables included relief of nighttime
heartburn, change in the PSQI global score, and changes in work
productivity as assessed by the Work Productivity and Activity
Impairment questionnaire. A signiﬁcantly higher percentage of
patients reported relief (no heartburn on six of seven nights), and
complete resolution (no heartburn on seven nights) of symptoms
with treatment compared with those taking placebo. There was no
signiﬁcant difference between the 40 mg and 20 mg doses of eso-
meprazole; approximately 50% of treated patients had relief of
nighttime heartburn symptoms compared with approximately 13%
on placebo. Approximately 82% of patients in the treatment arms
reported relief of GERD-associated sleep disturbance compared
with 55% on placebo. The PSQI data, which measures general sleep
quality, showed a signiﬁcant improvement to nearly normal levels
in both treatment groups. It was documented that approximately
16 work hours were lost due to GERD-related sleep disturbances at
baseline; this was improved to approximately 12 hours subsequent
to treatment. Using an average total employee compensation cost
of $24.59 (USD) per hour, the cost of hours saved per patient per
week was approximately $290.00 (USD) in the two treatment
groups. Indeed, results of a recent internet survey showed that
GERD-related symptom severity was strongly associated with work
impairment, and that nighttime GERD was associated with
substantially greater work impairment, as was symptom severity
[18]. In a smaller study using polysomnography to deﬁne sleep
parameters, rabeprazole 20 mg once daily was shown to improve
subjective sleep measures without any change in the objective
sleep measures [19]. Additionally, another study done by Dimarino
et al, using polysomnography during esophageal pH monitoring,
showed that omeprazole 20 mg twice daily improved the objective
sleepmeasures (reﬂux-related arousals and awakenings) in a group
of patients with sleep complaints and GER [20].
In a recent study, Fass et al evaluated the efﬁcacy of dexlanso-
prazole in relieving nocturnal heartburn, reducing sleep distur-
bances, improving work productivity, and decreasing nocturnal
symptom severity in patients with symptomatic GERD [21]. This
randomized, double-blind study enrolled patients (n ¼ 305) with
frequent, moderate-to-very severe nocturnal heartburn and asso-
ciated sleep disturbances. They received dexlansoprazole modiﬁed
release (MR) (not currently available in Taiwan) 30 mg or placebo
once daily for 4 weeks. The primary end point was the percentage
of nights without heartburn, whereas secondary end points were
the percentage of patients with relief of nocturnal heartburn and of
GERD-related sleep disturbances over the last 7 days of treatment.
Dexlansoprazole MR 30 mg (n ¼ 152) was superior to placebo
(n ¼ 153) in terms of the median percentage of nights without
heartburn (73.1 vs. 35.7%, respectively; p < 0.001), and relief of
nocturnal heartburn and GERD-related sleep disturbances (47.5 vs.
19.6 %, 69.7 vs. 47.9 %, respectively; p < 0.001), and led to signiﬁ-
cantly greater improvements in sleep quality andwork productivity
and decreased nocturnal symptom severity. It was concluded that
in patients with symptomatic GERD, dexlansoprazole MR 30 mg is
signiﬁcantly more efﬁcacious than placebo in providing relief from
nocturnal heartburn, in reducing GERD-related sleep disturbances
and the consequent impairments in work productivity, and in
improving sleep quality and QOL.
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GER is a symptom commonly observed in patients with
obstructive sleep apnea (OSA), and patients with both GER and OSA
have been shown to have signiﬁcantly poorer QOL compared with
patients with OSA alone [22]. OSA occurs in about 4% of adult men
and 2% of adult women [23]. Recent studies have revealed that risk
factors for OSA included male sex (OR ¼ 3.7; CI ¼ 1.63e8.19),
age > 65 years (OR ¼ 2.4; CI ¼ 0.65e8.54), and BMI (OR ¼ 1.5;
CI ¼ 0.68e3.16), which were considered to be of clinical signiﬁ-
cance [24]. Among these, themost obvious shared risk with GERD is
obesity [25]. Further evidence supporting an association between
GERD and OSA was provided by a 24-hour esophageal pH moni-
toring study of 16 patients with OSA, which revealed 80% of those
patients had abnormally high esophageal acid exposure times [26].
Furthermore, a study of 16 patients with both OSA and GERD found
that improving breathing mechanics with continuous positive
airway pressure (CPAP) normalized the esophageal acid exposure in
81% of the patients and reduced themean acid exposure time of the
group from 12.4% before CPAP to 6.8% with CPAP [27]. However,
evidence for the relationship between GER and OSA has not been
found [26,28].
It is clinically well established that OSA is associated with
a profound degree of daytime sleepiness, depression, and irrita-
bility, all of which weigh heavily in diminishing QOL. GER exacer-
bates a signiﬁcant impairment in QOL to an even greater degree in
this patient population (i.e., thosewith sleep disorders). Despite the
intuitive assumption that upper airway obstruction predisposes to
GER, <4% of OSA episodes are observed to occur with reﬂux [20].
GERD was shown to be alleviated during OSA, with pressure
changes in both the upper and lower esophageal sphincters [29]. In
patients with both GERD and mild OSA, 8-week acid suppression
therapy led to a signiﬁcant resolution in sleep-related GERD,
without any improvement in the apnea index [30].
6. Summary and conclusions
Nighttime reﬂux symptoms, such as heartburn and acid regur-
gitation, are clinical manifestations that clearly mitigate QOL and
work performance; however, they remain to be symptoms which
are still commonly ignored. Patients with nighttime GER consis-
tently report that these nighttime symptoms disturb them more
than their daytime symptoms, and the resultant disturbance in
sleep and impaired daytime performance takes its toll in terms of
daily QOL. It is also evident that, although there are many causes of
sleepiness, nighttime GER is indeed associated with disturbed
sleep, and in a majority of these patients, sleep disturbances and
QOL can be markedly improved by eliminating the symptoms of
nighttime reﬂux as treated with acid suppression therapy.
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